Zurich Cantonal Bank’s Karyopharm Therapeutics KPTI Stock Holding History

Zurich Cantonal Bank’s Portfolio KPTI Stock Details KPTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Hold	0	–	-$9	–	2684
2024 Q1	–	Hold	0	–	–	–	2701
2023 Q4	–	Hold	0	–	–	–	2721
2023 Q3	–	Sell	-1,209	Closed	-$27.1K	–	2783
2023 Q2	$32.5K	Buy	1,209 +654	+118%	+$28.2K	﹤0.01%	2681
2023 Q1	$32.4K	Sell	555 -246	-31%	-$12.1K	﹤0.01%	2687
2022 Q4	$40.9K	Buy	801 +108	+16%	+$7.49K	﹤0.01%	2651
2022 Q3	$57K	Hold	693	–	–	﹤0.01%	2542
2022 Q2	$47K	Sell	693 -16	-2%	-$1.47K	﹤0.01%	2611
2022 Q1	$78K	Buy	709 +311	+78%	+$38.8K	﹤0.01%	2384
2021 Q4	$38K	Hold	398	–	–	﹤0.01%	2795
2021 Q3	$35K	Hold	398	–	–	﹤0.01%	2714
2021 Q2	$62K	Hold	398	–	–	﹤0.01%	2397
2021 Q1	$63K	Hold	398	–	–	﹤0.01%	2327
2020 Q4	$93K	Hold	398	–	–	﹤0.01%	2238
2020 Q3	$87K	Hold	398	–	–	﹤0.01%	2048
2020 Q2	$113K	Hold	398	–	–	﹤0.01%	1881
2020 Q1	$115K	Buy	398 +139	+54%	+$38.3K	﹤0.01%	1530
2019 Q4	$75K	Hold	259	–	–	﹤0.01%	1905
2019 Q3	$37K	Hold	259	–	–	﹤0.01%	2216
2019 Q2	$23K	Hold	259	–	–	﹤0.01%	2431
2019 Q1	$23K	Hold	259	–	–	﹤0.01%	2375
2018 Q4	$36K	Hold	259	–	–	﹤0.01%	2212
2018 Q3	$66K	Hold	259	–	–	﹤0.01%	1977
2018 Q2	$66K	Buy	+259	New	+$64.1K	﹤0.01%	1937

Other funds holding KPTI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Zurich Cantonal Bank's KPTI Position: Q2 2024 in Review

Zurich Cantonal Bank held its Karyopharm Therapeutics (KPTI) position steady in Q2 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2684.

Zurich Cantonal Bank first reported a position in KPTI in Q2 2018 and has held it in 21 quarters since. The position peaked at $115K in Q1 2020. 114 funds tracked by Wall St. Rank hold KPTI as of Q2 2024.

Zurich Cantonal Bank held 0 shares of Karyopharm Therapeutics worth $0 as of Q2 2024.
Zurich Cantonal Bank left its Karyopharm Therapeutics share count unchanged in Q2 2024.
Karyopharm Therapeutics made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2024, its #2684 holding.
Zurich Cantonal Bank first reported a position in Karyopharm Therapeutics in Q2 2018 and has held it in 21 quarters since.
Zurich Cantonal Bank's Karyopharm Therapeutics position peaked at $115K in Q1 2020.
114 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q2 2024.

Based on Zurich Cantonal Bank's 13F filing for Q2 2024, filed 29 Jul 2024.